Literature DB >> 34225819

Identification of potential biomarkers for pathogenesis of Alzheimer's disease.

Huimin Wang1, Xiujiang Han2, Sheng Gao3.   

Abstract

BACKGROUND: Alzheimer's disease (AD) is an extremely complicated neurodegenerative disorder, which accounts for almost 80 % of all dementia diagnoses. Due to the limited treatment efficacy, it is imperative for AD patients to take reliable prevention and diagnosis measures. This study aimed to explore potential biomarkers for AD.
METHODS: GSE63060 and GSE140829 datasets were downloaded from the Gene Expression Omnibus (GEO) database. The differentially expressed genes (DEG) between AD and control groups in GSE63060 were analyzed using the limma software package. The mRNA expression data in GSE140829 was analyzed using weighted gene co-expression network analysis (WGCNA) function package. Protein functional connections and interactions were analyzed using STRING and key genes were screened based on the degree and Maximal Clique Centrality (MCC) algorithm. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were performed on the key genes.
RESULTS: There were 65 DEGs in GSE63060 dataset between AD patients and healthy controls. In GSE140829 dataset, the turquoise module was related to the pathogenesis of AD, among which, 42 genes were also differentially expressed in GSE63060 dataset. Then 8 genes, RPS17, RPL26, RPS3A, RPS25, EEF1B2, COX7C, HINT1 and SNRPG, were finally screened. Additionally, these 42 genes were significantly enriched in 12 KEGG pathways and 119 GO terms.
CONCLUSIONS: In conclusion, RPS17, RPL26, RPS3A, RPS25, EEF1B2, COX7C, HINT1 and SNRPG, were potential biomarkers for pathogenesis of AD, which should be further explored in AD in the future.

Entities:  

Keywords:  Alzheimer's disease; Biomarker; Differentially expressed genes; Weighted gene co-expression network analysis

Year:  2021        PMID: 34225819     DOI: 10.1186/s41065-021-00187-9

Source DB:  PubMed          Journal:  Hereditas        ISSN: 0018-0661            Impact factor:   3.271


  2 in total

Review 1.  Therapeutic approaches to Alzheimer's disease through stimulating of non-amyloidogenic processing of amyloid precursor protein.

Authors:  Y-Q Wang; D-H Qu; K Wang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2016-06       Impact factor: 3.507

Review 2.  Amyloid-beta Alzheimer targets - protein processing, lipid rafts, and amyloid-beta pores.

Authors:  Sage C Arbor; Mike LaFontaine; Medhane Cumbay
Journal:  Yale J Biol Med       Date:  2016-03-24
  2 in total
  3 in total

1.  Identification and Validation of Novel Potential Pathogenesis and Biomarkers to Predict the Neurological Outcome after Cardiac Arrest.

Authors:  Qiang Zhang; Chenyu Zhang; Cong Liu; Haohong Zhan; Bo Li; Yuanzhen Lu; Hongyan Wei; Jingge Cheng; Shuhao Li; Chuyue Wang; Chunlin Hu; Xiaoxing Liao
Journal:  Brain Sci       Date:  2022-07-15

2.  Development and validation of immune-based biomarkers and deep learning models for Alzheimer's disease.

Authors:  Yijie He; Lin Cong; Qinfei He; Nianping Feng; Yun Wu
Journal:  Front Genet       Date:  2022-08-22       Impact factor: 4.772

3.  Identification of the molecular subgroups in Alzheimer's disease by transcriptomic data.

Authors:  He Li; Meiqi Wei; Tianyuan Ye; Yiduan Liu; Dongmei Qi; Xiaorui Cheng
Journal:  Front Neurol       Date:  2022-09-20       Impact factor: 4.086

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.